Literature DB >> 11171114

Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin.

R Korhonen1, H Kankaanranta, A Lahti, M Lähde, R G Knowles, E Moilanen.   

Abstract

Nitric oxide produced through the action of inducible nitric oxide synthase (iNOS) is an important mediator in immune responses of the host. Various extracellular factors, including inflammatory stimuli, affect intracellular free Ca2+ levels ([Ca2+](i)), modulating cellular signalling and gene expression. In the present study we investigated the effects of increased ([Ca2+](i)) on NO production through the iNOS pathway in J774 macrophages. Thapsigargin (TG), a Ca2+-ATPase inhibitor, and the Ca2+ ionophore A23187 were used as tools to induce an increase in ([Ca2+](i)) in the cytosol. This increase was confirmed by the fura 2 method. The production of NO was measured as accumulated nitrite in the cell culture medium; iNOS protein and iNOS mRNA were detected by Western blotting and reverse-transcriptase-mediated PCR respectively. The activation of nuclear factor kappaB (NF-kappaB) was investigated by electrophoretic mobility-shift assay. TG (100 nM) induced a marked synthesis of iNOS mRNA, iNOS protein and NO in cells primed with a low concentration of endotoxin [lipopolysaccharide (LPS) 1 ng/ml], which on its own induced barely detectable NO synthesis. Stimulation by a high concentration of LPS (100 ng/ml) induced a marked expression of iNOS and NO production. Under these conditions, treatment with TG hindered the synthesis of iNOS protein and NO production by accelerating the degradation of iNOS mRNA. Treatment with TG (100 nM) did not affect the NF-kappaB activity induced by low (1 ng/ml) or high (100 ng/ml) concentrations of LPS. Viability of the cells was confirmed by the 2,3-bis[2-methoxy-4-nitro-5-sulphophenyl]-2H-tetrazolium-5-carboxyaniline ("XTT") method; apoptosis was ruled out by propidium iodide staining and flow cytometry. A23187 (1 microM) also transiently increased ([Ca2+](i)) and had opposite effects on NO production depending on the LPS concentration. Our results show that increased ([Ca2+](i)) induced the stimulation or suppression of NO production through iNOS in macrophages depending on the state of cell activation. These findings suggest that the receptor-mediated increase in ([Ca2+](i)) might be an important factor in the control of the balance between the up-regulation and down-regulation of inflammatory genes, including that encoding iNOS, depending on the phase of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171114      PMCID: PMC1221663          DOI: 10.1042/0264-6021:3540351

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Inducible nitric-oxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process.

Authors:  T Evans; A Carpenter; J Cohen
Journal:  Eur J Biochem       Date:  1994-01-15

Review 2.  Calcium regulation of gene expression.

Authors:  L B Rosen; D D Ginty; M E Greenberg
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1995

3.  Involvement of intracellular Ca2+ in oxidant-induced NF-kappa B activation.

Authors:  C K Sen; S Roy; L Packer
Journal:  FEBS Lett       Date:  1996-04-29       Impact factor: 4.124

Review 4.  Molecular mechanisms and therapeutic strategies related to nitric oxide.

Authors:  S Moncada; E A Higgs
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

5.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.

Authors:  Q W Xie; Y Kashiwabara; C Nathan
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

6.  Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium.

Authors:  L C Denlinger; P L Fisette; K A Garis; G Kwon; A Vazquez-Torres; A D Simon; B Nguyen; R A Proctor; P J Bertics; J A Corbett
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

7.  Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells.

Authors:  M Bereta; J Bereta; I Georgoff; F D Coffman; S Cohen; M C Cohen
Journal:  Exp Cell Res       Date:  1994-06       Impact factor: 3.905

8.  Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method.

Authors:  H Wong; W D Anderson; T Cheng; K T Riabowol
Journal:  Anal Biochem       Date:  1994-12       Impact factor: 3.365

9.  Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes.

Authors:  H Kankaanranta; E Moilanen
Journal:  Mol Pharmacol       Date:  1995-05       Impact factor: 4.436

10.  Increased intracellular Ca2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability.

Authors:  Y Geng; M Lotz
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  13 in total

1.  Transient Receptor Potential Ankyrin 1 (TRPA1) Mediates Lipopolysaccharide (LPS)-Induced Inflammatory Responses in Primary Human Osteoarthritic Fibroblast-Like Synoviocytes.

Authors:  Songjiang Yin; Peimin Wang; Runlin Xing; Linrui Zhao; Xiaochen Li; Li Zhang; Yancheng Xiao
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 2.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

3.  The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53.

Authors:  Tohru Yamada; Masatoshi Goto; Vasu Punj; Olga Zaborina; Kazuhide Kimbara; T K Das Gupta; A M Chakrabarty
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Nitric oxide and calcium ions in apoptotic esophageal carcinoma cells induced by arsenite.

Authors:  Zhong-Ying Shen; Wen-Ying Shen; Ming-Hua Chen; Jian Shen; Wei-Jie Cai; Zeng Yi
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

5.  Effects of strains of Lactococcus lactis on the production of nitric oxide and cytokines in murine macrophages.

Authors:  Chise Suzuki; Ayako Aoki-Yoshida; Hiromi Kimoto-Nira; Miho Kobayashi; Keisuke Sasaki; Koko Mizumachi
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

6.  Simultaneously multi-parameter determination of hematonosis cell apoptosis by two-photon and confocal laser scanning microscopy.

Authors:  Yi Wang; Xue-Feng Wang; Chen Wang; Hui Ma
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

7.  Conjugated linoleic acids and CLA-containing phospholipids inhibit NO formation in aortic endothelial cells.

Authors:  Kimberly J Jenko; Jack Y Vanderhoek
Journal:  Lipids       Date:  2008-03-12       Impact factor: 1.880

8.  Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1.

Authors:  Riku Korhonen; Tuija Hömmö; Tiina Keränen; Mirka Laavola; Mari Hämäläinen; Katriina Vuolteenaho; Lauri Lehtimäki; Hannu Kankaanranta; Eeva Moilanen
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Induction of TLR4-target genes entails calcium/calmodulin-dependent regulation of chromatin remodeling.

Authors:  Dazhi Lai; Mimi Wan; Jie Wu; Paula Preston-Hurlburt; Ritu Kushwaha; Thomas Grundström; Anthony N Imbalzano; Tian Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  Urate crystal induced inflammation and joint pain are reduced in transient receptor potential ankyrin 1 deficient mice--potential role for transient receptor potential ankyrin 1 in gout.

Authors:  Lauri J Moilanen; Mari Hämäläinen; Lauri Lehtimäki; Riina M Nieminen; Eeva Moilanen
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.